EP4122452A1 — Pharmaceutical composition comprising nilotinib and method of manufacturing the same
Assigned to KRKA dd · Expires 2023-01-25 · 3y expired
What this patent protects
The present invention provides methods for preparing nilotinib-containing pharmaceutical compositions. The methods of the invention rely on a step of hot melt granulation employing a polyethylene glycol meltable binder. Pharmaceutical compositions obtainable by such methods are a…
USPTO Abstract
The present invention provides methods for preparing nilotinib-containing pharmaceutical compositions. The methods of the invention rely on a step of hot melt granulation employing a polyethylene glycol meltable binder. Pharmaceutical compositions obtainable by such methods are also provided.
Drugs covered by this patent
- nilotinib-hydrochloride (Nilotinib Hydrochloride) · Jan Beumer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.